Study on the Safety and Efficacy of RAG-21 in the Treatment of Amyotrophic Lateral Sclerosis Patients With FUS Gene Mutations
Clinical trial NCT07080801 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07080801
- Sponsor
- Beijing Tiantan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.